laitimes

CR Shuanghe Enalapril maleate tablets passed the consistency evaluation of generic drugs

Shanghai Securities News China Securities Network News (reporter Confucius Ziyuan) China Resources Shuanghe announced that the company's wholly-owned subsidiary Shuanghe Limin received the "Notice of Approval of Drug Supplement Application" issued by the State Drug Administration of Enalapril maleate tablets, and the drug passed the consistency evaluation of the quality and efficacy of generic drugs. The drug is used to treat all stages of primary hypertension, renovascular hypertension, heart failure at all levels, prevention of symptomatic heart failure, prevention of coronary artery ischemia events in patients with left ventricular dysfunction.

CR Shuanghe Enalapril maleate tablets passed the consistency evaluation of generic drugs

Read on